Professional Documents
Culture Documents
Available in
6 Fr
CONFIGURATIONS
H E P A R I N
B I O A C T I V E S U R F A C E
PERFORMANCE
through innovation
Indicated for Use in the Superficial Femoral and Iliac Arteries (5 8 mm diameters)
Endoprosthesis
Labeled
Diameter 1 (mm)
Endoprosthesis
Length 1 (cm)
Catheter
Length 2 (cm)
Recommended
Vessel
Diameter 3 (mm)
Device
Profile (Fr)
Recommended
Balloon
Diameter
for Device
Touch-up 5 (mm)
VBH050202
2.5
120
4.0 4.7
0.035"
VBH050502
5.0
120
4.0 4.7
0.035"
VBH051002
10.0
120
4.0 4.7
0.035"
VBH051502
15.0
120
4.0 4.7
0.035"
VBJ050202
2.5
120
4.0 4.7
0.018" or 0.014"
VBJ050502
5.0
120
4.0 4.7
0.018" or 0.014"
VBJ051002
10.0
120
4.0 4.7
0.018" or 0.014"
VBJ051502
15.0
120
4.0 4.7
0.018" or 0.014"
VBH060201
2.5
75
4.8 5.5
0.035"
VBH060202
2.5
120
4.8 5.5
0.035"
VBH060501
5.0
75
4.8 5.5
0.035"
VBH060502
5.0
120
4.8 5.5
0.035"
VBH061001
10.0
75
4.8 5.5
0.035"
VBH061002
10.0
120
4.8 5.5
0.035"
VBH061501
15.0
75
4.8 5.5
0.035"
VBH061502
15.0
120
4.8 5.5
0.035"
VBJ060202
2.5
120
4.8 5.5
0.018" or 0.014"
VBJ060502
5.0
120
4.8 5.5
0.018" or 0.014"
VBJ061002
10.0
120
4.8 5.5
0.018" or 0.014"
VBJ061502
15.0
120
4.8 5.5
0.018" or 0.014"
VBH070201
2.5
75
5.6 6.5
0.035"
VBH070202
2.5
120
5.6 6.5
0.035"
VBH070501
5.0
75
5.6 6.5
0.035"
VBH070502
5.0
120
5.6 6.5
0.035"
VBH071001
10.0
75
5.6 6.5
0.035"
VBH071002
10.0
120
5.6 6.5
0.035"
VBH071501
15.0
75
5.6 6.5
0.035"
VBH071502
15.0
120
5.6 6.5
0.035"
VBJ070202
2.5
120
5.6 6.5
0.018" or 0.014"
VBJ070502
5.0
120
5.6 6.5
0.018" or 0.014"
VBJ071002
10.0
120
5.6 6.5
0.018" or 0.014"
VBJ071502
15.0
120
5.6 6.5
0.018" or 0.014"
Catalogue
Number
Guidewire
Compatibility
Endoprosthesis
Labeled
Diameter 1 (mm)
Endoprosthesis
Length 1 (cm)
Catheter
Length 2 (cm)
Recommended
Vessel
Diameter 3 (mm)
Device
Profile (Fr)
Recommended
Balloon
Diameter
for Device
Touch-up 5 (mm)
VBH080201
2.5
75
6.6 7.5
0.035"
VBH080202
2.5
120
6.6 7.5
0.035"
VBH080501
5.0
75
6.6 7.5
0.035"
VBH080502
5.0
120
6.6 7.5
0.035"
VBH081001
10.0
75
6.6 7.5
0.035"
VBH081002
10.0
120
6.6 7.5
0.035"
VBH081501
15.0
75
6.6 7.5
0.035"
VBH081502
15.0
120
6.6 7.5
0.035"
VBJ080202
2.5
120
6.6 7.5
0.018" or 0.014"
VBJ080502
5.0
120
6.6 7.5
0.018" or 0.014"
VBJ081002
10.0
120
6.6 7.5
0.018" or 0.014"
VBJ081502
15.0
120
6.6 7.5
0.018" or 0.014"
Guidewire
Compatibility
Catalogue
Number
Guidewire
Compatibility
Catheter
Length 2 (cm)
Recommended
Vessel
Diameter 3 (mm)
Device
Profile (Fr)
Recommended
Balloon
Diameter
for Device
Touch-up 5 (mm)
5.0
120
7.6 8.5
0.035"
10.0
120
7.6 8.5
0.035"
VBH091502
15.0
120
7.6 8.5
0.035"
VBH100202
10
2.5
120
8.6 9.5
114
10
0.035"
VBH100502
10
5.0
120
8.6 9.5
114
10
0.035"
VBH101002
10
10.0
120
8.6 9.5
114
10
0.035"
VBH101502
10
15.0
120
8.6 9.5
114
10
0.035"
VBH110202
11
2.5
120
9.6 10.5
11
12
0.035"
VBH110502
11
5.0
120
9.6 10.5
11
12
0.035"
VBH111002
11
10.0
120
9.6 10.5
11
12
0.035"
VBH130202
13
2.5
120
10.6 12.0
12
14
0.035"
VBH130502
13
5.0
120
10.6 12.0
12
14
0.035"
VBH131002
13
10.0
120
10.6 12.0
12
14
0.035"
Endoprosthesis
Labeled
Diameter 1 (mm)
Endoprosthesis
Length 1 (cm)
VBH090502
VBH091002
Catalogue
Number
TIP to HUB
Device Deployment
3
4
INTENDED USE / INDICATIONS The GORE VIABAHN Endoprosthesis is indicated for improving blood flow in
patients with symptomatic peripheral arterial disease in superficial femoral artery lesions with reference vessel
diameters ranging from 4.0 7.5 mm. The GORE VIABAHN Endoprosthesis is indicated for improving blood flow
in patients with symptomatic peripheral arterial disease in iliac artery lesions with reference vessel diameters
ranging from 4.0 12 mm. CONTRAINDICATIONS The GORE VIABAHN Endoprosthesis is contraindicated for
non-compliant lesions where full expansion of an angioplasty balloon catheter was not achieved during predilatation, or where lesions cannot be dilated sufficiently to allow passage of the delivery system. Do not use
the GORE VIABAHN Endoprosthesis with Heparin Bioactive Surface in patients with known hypersensitivity to
heparin, including those patients who have had a previous incidence of Heparin-Induced Thrombocytopenia
(HIT) type II.